medigraphic.com

2018, Number 1

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2018; 56 (1)

Characterization of stroke patients attended at IMSS hospitals in Mexico City

Torres-Arreola LP, Valenzuela-Flores AA, Villa-Barragán JP

Language: Spanish
References: 29
Page: 18-25
PDF size: 420.77 Kb.


ABSTRACT

Background: Cerebrovascular disease (CD) is considered a problem of huge social, economic and public health implications worldwide in adults and elderly. In Mexico, the information concerning the provision of services to people and their characteristics is limited. The objective is to describe the characteristics of patients with CV who attended the hospitals of the Instituto Mexicano del Seguro Social (IMSS) in Mexico City.
Methods: It was carried out a cohort study of patients with ischemic or hemorrhagic CD who arrived to IMSS. Patients were recruited from seven IMSS general hospitals in Mexico City from June, 2013, to October, 2014.
Results: We assigned 430 subjects with CD (78.14% had ischemic CD). There were no statistical differences regarding gender. The median age of patients was 74 years. During their first 72 hours of hospital stay, it was assessed language proficiency in 90%, the ability to walk in 16.3% and the ability to move extremities in 94%. The main risk factors were hypertension, 84%; diabetes mellitus, 46.3%; history of CD, 25.1%; smoking history, 13.7%. 80% of patients reported that their health was regular or poor.
Conclusions: General characteristics of patients and vascular risk factors are similar to those reported by other studies. Secondary prevention strategies are performed in less time than that recommended by international standards. It is urgent to design strategies to build better ways of care during the acute phase of patients with CD.


REFERENCES

  1. Langhorne P, Williams BO, Gilchrist W, Howie K. Do stroke units save lives. Lancet 1993;342(8868): 395-8.

  2. Kalra L, Evans A, Perez I, Knapp M, Swift C, Donaldson N. A randomised controlled comparison of alternative strategies in stroke care. Health Technol Assess. 2005, May;9(18):iii-iv, 1-79.

  3. [No authors listed]. Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke. Stroke Unit Trialists’ Collaboration. BMJ. 1997 Apr 19;314(7088):1151-9.

  4. García-García JJ. Perfil Epidemiológico del Adulto Mayor en México. Archivo Geriátrico. 2000;3:79-83.

  5. Thorvaldsen P, Asplund K, Kuulasmaa K, Rajakangas AM, Schroll M. Stroke incidence, case fatality, and mortality in the WHO MONICA project. World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease. Stroke. 1995 Mar;26(3):361-7.

  6. Carandang R, Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Kannel WB, et al. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA. 2006 Dec 27;296 (24):2939-46.

  7. Thrift AG, Dewey HM, Sturm JW, Srikanth VK, Gilligan AK, Gall SL, et al. Incidence of stroke subtypes in the North East Melbourne Stroke Incidence Study (NEMESIS): differences between men and women. Neuroepidemiology. 2009;32(1):11-8.

  8. Feigin VL1, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009 Apr; 8 (4):355-69.

  9. Johnston SC, Mendis S, Mathers CD. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol. 2009 Apr;8(4):345-54.

  10. Wolf PA, D’Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991;22(3):312-8.

  11. Den Ruijter HM, Peters SA, Anderson TJ, Britton AR, Dekker JM, Eijkemans MJ, et al. Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA. 2012;308(8):796-803.

  12. Kirshner HS. Differentiating ischemic stroke subtypes: risk factors and secondary prevention. J Neurol Sci. 2009 Apr 15;279(1-2):1-8.

  13. Harmsen P, Lappas G, Rosengren A, Wilhelmsen L. Long-term risk factors for stroke: twenty-eight years of follow-up of 7457 middle-aged men in Göteborg, Sweden. Stroke. 2006 Jul;37(7):1663-7.

  14. Moreno VP, García-Raso A, García-Bueno MJ, Sánchez-Sánchez C, Meseguer E, Mata R, et al. Factores de riesgo vascular en pacientes con ictus isquémico. Distribución según edad, sexo y subtipo de ictus. Rev Neurol. 2008;46(10):593-8.

  15. Sistema Nacional de Información en Salud. Boletín de información estadística 2014-2015. México: DGIS, SINAIS. Disponible en http://www.dgis.salud.gob.mx/ contenidos/basesdedatos/estandar_gobmx.html

  16. Cabrera-Rayo A, Martínez-Olazo O, Laguna-Hernández G, Juárez-Ocaña R, Rosas-Barrientos V, Loria-Castellanos J et al. Epidemiología de la enfermedad vascular cerebral en hospitales de la Ciudad de México. Estudio multicéntrico, Med Int Mex. 2008;24(2):98-103.

  17. Ruiz-Matus C, Meneses-González F. Mortalidad por enfermedad vascular cerebral en México. Bol Mens Epidemiol. 1993;8:113.

  18. Institute for Health Metrics and Evaluation. GBD. Disponible en https://vizhub.healthdata.org/gbdcompare/ [Consultado el 14 de abril de 2015.]

  19. Sistema Único de Información-13 (SUI-13). Base de Egresos Hospitalarios 2010. México: Instituto Mexicano del Seguro Social, División Informática en Salud.

  20. Barinagarrementería F, Ruiz-Sandoval JL, Arauz A, Amaya L, Cantú C. A hospital stroke register in Mexico City: analysis of 2045 patients. Neurology. 1999;52 (Suppl 2): S442.

  21. Cumming TB, Churilov L, Linden T, Bernhardt J. Montreal Congnitive Assessment and Mini-Mental State Examination are both valid cognitive tolos in stroke. Acta Neurol Scand. 2013;128(2):122-9.

  22. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med. 1965;14:61-5.

  23. Baztán JJ, Pérez del Molino J, Alarcón T, San Cristóbal E, Izquierdo G, Manzarbeitia J. Indice de Barthel: instrumento válido para la valoración funcional de pacientes con enfermedad cerebrovascular. Rev Esp Geriatr Gerontol. 1993;28:32-40.

  24. Ware JE Jr, Sherbourne CD. The MOS 36 item shortform health survey (SF--36). I. Conceptual framework and item selection. Medical Care. 1992;30(6):473-83.

  25. Banks JL, Marotta CA. Outcomes Validity and Reliability of the Modified Rankin Scale: Implications for Stroke Clinical Trials. Stroke. 2007;38:1091-6.

  26. Cantú-Brito C, Ruíz-Sandoval JL, Murillo-Bonilla LM, Chiquete E, León-Jimenéz C, Arauz A et al. Manejo agudo y pronóstico a un año en pacientes mexicanos con un primer infarto cerebral: resultados del estudio multicentrico PREMIER. Rev Neurol. 2010;51(11): 541-649.

  27. Kapral MK, Laupacis A, Phillips SJ, Silver FL, Hill MD, Fang J, et al. Stroke care delivery in institutions paricipating in the registry of the Canadian Stroke Network. Stroke. 2004;35:1756-62.

  28. Liu X, Xu G, Wu W, Zhang R, Yin Q, Zhu W. Subtypes and one-year survival of first-ever stroke in Chinese patients: The Nanjing Stroke Registry. Cerebrovasc Dis. 2006;22(2-3):130-6.

  29. Arrospide-Elgarresta A, Mar J, Vivancos-Mora, Rejas-Gutiérrez J, Caro J. Estudio coste-efectividad del uso de dosis altas de artovastatina en la prevención secundaria del ictus en España. Rev Neurol. 2010;51:1-11.




2020     |     www.medigraphic.com